Related News

May 13, 2020

SmarTrend identified a Downtrend for Catalent Inc (NYSE:CTLT) on March 25th, 2020 at $47.96. In approximately 2 months, Catalent Inc has returned 52.75% as of today's recent price of $73.25.

Catalent Inc...

May 11, 2020

Catalent Inc (NYSE:CTLT) traded in a range yesterday that spanned from a low of $71.96 to a high of $73.64. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $73.40 on...

May 5, 2020

SmarTrend identified a Downtrend for Catalent Inc (NYSE:CTLT) on March 25th, 2020 at $47.96. In approximately 1 month, Catalent Inc has returned 41.16% as of today's recent price of $67.70.

Catalent Inc...

April 29, 2020

Catalent Inc (NYSE:CTLT) traded in a range yesterday that spanned from a low of $66.38 to a high of $69.43. Yesterday, the shares gained 7.7%, which took the trading range above the 3-day high of $64.32 on...

April 16, 2020

SmarTrend identified a Downtrend for Catalent Inc (NYSE:CTLT) on March 25th, 2020 at $47.96. In approximately 3 weeks, Catalent Inc has returned 15.69% as of today's recent price of $55.48.

In the past 52...

April 13, 2020

Below are the three companies in the Pharmaceuticals industry with the highest debt to asset ratios. The Debt/Asset ratio shows the proportion of a company's assets that are financed through debt. If the ratio is greater than one, most of the...

April 13, 2020

Below are the three companies in the Pharmaceuticals industry with the highest price to cash flow ratios. Often companies with the lowest ratio present the greatest value to investors.

Amphastar Pharma ranks highest with a a price to cash...

April 7, 2020

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Omeros...

March 31, 2020

Below are the three companies in the Pharmaceuticals industry with the highest year-over-year expected earnings per share (EPS) growth rates.

Horizon Pharma P ranks highest with a EPS growth of 38,527.3%. Following is Pacira Pharmaceu...

March 29, 2020

Below are the three companies in the Pharmaceuticals industry with the highest debt to equity ratios. The Debt/Equity ratio measures a company's leverage and a high level often implies that a company has financed much of its growth with debt....